6649 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Taiwan Biomaterial Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical equipment. It produces foamagen, stroke interventional treatment devices, early degenerative arthritis tissue repair and regeneration products. The company was founded by Hsiao Hsiung Ko, Chun Jen Liao and Wen Hsi Wang on November 12, 2012 and is headquartered in Zhubei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6649 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company